Act now to reduce impact of staffing crisisNICE backs oral DVT treatment
The National Institute for Health and Clinical Excellence has published final draft guidance recommending rivaroxaban (Xarelto) as a treatment for deep vein thrombosis.
Continue reading - simply register below
It only takes two minutes to do and you'll immediately have access to our news and opinion articles and you'll be able to sign up for our newsletters.
Already registered?
To check that you are registered please enter your email address below
Not registered?
Registration is free and takes just two minutes. After you register, you'll get access to our news and opinion stories and you'll be able to sign up to our newsletters.
